Ruffolo Robert R

DirectorLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Disposed to issuer(D)7170
Sep 10, 2025Grant(A)717717
Sep 10, 2025Disposed to issuer(D)11K0
Sep 10, 2025Grant(A)11K11K
Sep 10, 2025Grant(A)22K$022K
Sep 10, 2025Disposed to issuer(D)2K0
Sep 10, 2025Grant(A)2K2K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-024449) within minutes of acceptance. Every field above traces to the original document. Verify it directly: